Cargando…
Assessment of Serum Cystatin C Levels in Newly Diagnosed Acute Myocardial Infarction at the Onset and at the Time of Hospital Discharge
BACKGROUND: Cystatin C (Cys-C) is a marker of renal damage. Higher serum levels of Cys-C were observed in cardiovascular disease. This study aimed to test the null hypothesis that Cys-C levels in newly diagnosed acute myocardial infarction (AMI) may remain high in the survival and the impact of the...
Autores principales: | Alhusseiny, Adil H., Al-Nimer, Marwan S. M., Al-Neamy, Sarah Isam Attallah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295558/ https://www.ncbi.nlm.nih.gov/pubmed/28197230 http://dx.doi.org/10.14740/cr377w |
Ejemplares similares
-
Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: Its relation to the platelet indices
por: Al-Nimer, Marwan S M, et al.
Publicado: (2018) -
Electromagnetic Energy Radiated from Mobile Phone Alters Electrocardiographic Records of Patients with Ischemic Heart Disease
por: Alhusseiny, AH, et al.
Publicado: (2012) -
Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Obayashi, Yuki, et al.
Publicado: (2021) -
Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults
por: Ding, Qinglan, et al.
Publicado: (2021) -
Clinical Significance of Newly Diagnosed Diabetes Mellitus in the Era of DES for Acute Myocardial Infarction
por: Park, Hun-Jun
Publicado: (2018)